Closing the Treatment Gap with Inpatient and Emergency Department Initiated Medication Assisted Treatment (MAT) for Opioid-Use Disorder (OUD)

January 23, 2020

This webinar will describe one organizations approach to implementing MAT for OUD in the emergency department and inpatient care units.  Challenges such as EMR implementation, lack of physician support, challenges to getting physicians waivered and transitions in patient care will be discussed and resources and solutions will be provided.

Target Audience

Nurses

Pharmacists

Physician

Learning Objectives

Describe the critical elements required to implement an opioid use disorder treatment program in the emergency department and inpatient care locations

Discuss the challenges commonly associated with implementation of medication assisted therapy

Assess implementation challenges and strengths unique to community and rural hospitals

Additional Information

AttachmentSize
File Helpful Tips for Users23.29 KB
File Live Information for CE124.96 KB
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 CBRN
  • 1.00 General CE - Attendance
Course opens: 
12/11/2019
Course expires: 
03/08/2020
Event starts: 
01/23/2020 - 1:00pm CST
Event ends: 
01/23/2020 - 2:00pm CST
Webinar
United States

Relevant financial relationships: None of the planning committee and/or presenters have anything to disclose.


Planning committee members

Evan Schwarz, MD FACEP, FACMT
Associate Professor of Emergency Medicine
Medical Toxicology Fellowship Director
Section Chief Medical Toxicology
Advisory Dean in the Office of Student Affairs
Division of Emergency Medicine
Washington University School of Medicine
 
Amanda Hays, PharmD., MHA, BCPS, CPHQ
Director, Medication Safety and Effectiveness
BJC HealthCare
Center for Clinical Excellence

Jim Lichauer, PharmD, BCPS, FASHP
PI Program Director, Pharmacy
Vizient

Lindsay Mayer, RN, BSN, CPHQ
Director, Programs
Vizient

Course reviewer

Jim Lichauer, PharmD, BCPS, FASHP
PI Program Director, Pharmacy
Vizient

Lindsay Mayer, RN, BSN, CPHQ
Director, Programs
Vizient

Presenters

Evan Schwarz, MD FACEP, FACMT
Associate Professor of Emergency Medicine
Medical Toxicology Fellowship Director
Section Chief Medical Toxicology
Advisory Dean in the Office of Student Affairs
Division of Emergency Medicine
Washington University School of Medicine
 
Amanda Hays, PharmD., MHA, BCPS, CPHQ
Director, Medication Safety and Effectiveness
BJC HealthCare
Center for Clinical Excellence

Joint Accreditation Statement:

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Designation Statements:

NURSING
This activity is designated for 1.00 hours.

Vizient, Inc. is approved by the California Board of Registered Nursing, Provider Number CEP12580, for 1.20 contact hours.

PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours. 
Universal Activity Number: JA0006103-0000-20-016-L01-P

PHYSICIAN
Vizient, Inc. designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).


 

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 CBRN
  • 1.00 General CE - Attendance
Please login or register to take this course.